PacBio develops comprehensive solutions for scientists that propel the field of genomics, improve science and research, and create positive impact globally. We provide sophisticated genomic analysis systems that deliver invaluable insights for scientists who strive to resolve complex genetic challenges. Our strength comes from the dedication of our people, who are fueled by a desire to effect real, positive change. With a focus on the future and an experienced, passionate team, we are motivated to continue to redefine what is possible in genomics.
Location: United States, California, Menlo Park
Employees: 501-1000
Founded date: 2004
Investors 1
| Date | Name | Website |
| - | Transhuman... | transhuman... |
Mentions in press and media 8
| Date | Title | Description |
| 13.05.2024 | Azenta Opens the Doors to Its New Genomics Laboratory in Oxford, UK | BURLINGTON, Mass., May 13, 2024 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today announced the grand opening of the new Genomics Laboratory in Oxford, UK, expanding its global reach of GENEWIZ Multiomics & Synthesis Solutions further i... |
| 03.08.2023 | PacBio To Buy Apton Biosystems, For Up To $110M | PacBio (NASDAQ: PACB), a Menlo Park, CA-based developer of high-quality, highly accurate sequencing solutions, is to acquire Apton Biosystems, Inc., a Pleasanton, California-based company developing a high throughput short-read sequencer. T... |
| 08.07.2023 | PacBio and GeneDx Launches Research Collaboration | What You Should Know: PacBio, a developer of high-quality, highly accurate sequencing solutions and GeneDx, a provider in delivering improved health outcomes through genomic and clinical insights, today announced a research collaboration wi... |
| 09.04.2023 | PacBio Announces New Nanobind Extraction Kits to Enable High-Throughput Workflows with Revio and Sequel Systems | Kits Combine the Power of HiFi Sequencing and Nanobind Technology to Optimize Sample Preparation Workflows for High Volume Customers PacBio, a leading developer of high-quality, highly accurate sequencing solutions, announced the availabili... |
| 25.01.2023 | Pacific Biosciences of California, Inc. Announces Pricing of Upsized Public Offering of Common Stock | MENLO PARK, Calif., Jan. 24, 2023 /PRNewswire/ -- Pacific Biosciences of California, Inc. PACB ("PacBio") today announced that it has priced its previously announced underwritten public offering of 17,500,000 shares of its common ... |
| 13.01.2023 | Here are 5 winners and 4 losers from the healthcare industry's most important event of the year | Westend61/Getty Images This story is available exclusively to Insider subscribers. Become an Insider and start reading now. The healthcare industry's most influential investor conference was held in person this week. The J.P. Morgan Healthc... |
| 25.02.2022 | Tillman Gerngross leads a pack of biotech CEOs out the door; With eyes on pipeline expansion, Poseida woos a gene therapy exec from Novartis | Tillman Gerngross As market volatility sweeps through the landscape, CEO changes are really ramping up, and topping the list is Tillman Gerngross, a force in the antibody space who hitched his wagon to finding another Covid-19 solution by c... |
| 04.08.2021 | A Silicon Valley sequencing leader acquired Baltimore biotech company Circulomics | Circulomics, a downtown Baltimore biotech startup that spun out of Johns Hopkins University, was acquired by Pacific Biosciences, a publicly traded company based in Silicon Valley. Going forward, Circulomics’ team of about 10 people will co... |